ENSG00000137497 |
|
skin melanoma |
sequence_alteration |
2.068% (20/967) |
2 entries |
ENSG00000137497 |
|
female breast carcinoma |
sequence_alteration |
1.873% (5/267) |
1 entry |
ENSG00000137497 |
|
bladder transitional cell carcinoma |
sequence_alteration |
2.92% (4/137) |
2 entries |
ENSG00000137497 |
|
nasopharyngeal squamous cell carcinoma |
sequence_alteration |
1.198% (2/167) |
1 entry |
ENSG00000137497 |
|
breast carcinoma |
sequence_alteration |
1.063% (15/1411) |
1 entry |
ENSG00000137497 |
|
cecum adenocarcinoma |
missense_variant |
3.053% (4/131) |
1 entry |
ENSG00000137497 |
|
hepatocellular carcinoma |
missense_variant |
1.221% (11/901) |
1 entry |
ENSG00000137497 |
|
rectal adenocarcinoma |
sequence_alteration |
1.81% (4/221) |
1 entry |
ENSG00000137497 |
|
esophageal squamous cell carcinoma |
sequence_alteration |
1.778% (12/675) |
4 entries |
ENSG00000137497 |
|
colon adenocarcinoma |
missense_variant |
3.453% (26/753) |
6 entries |
ENSG00000137497 |
|
gastric intestinal type adenocarcinoma |
sequence_alteration |
8.235% (7/85) |
2 entries |
ENSG00000137497 |
|
small cell lung carcinoma |
missense_variant |
1.881% (6/319) |
3 entries |
ENSG00000137497 |
|
bladder transitional cell carcinoma |
missense_variant |
2.92% (4/137) |
1 entry |
ENSG00000137497 |
|
large cell lung carcinoma |
missense_variant |
11.11% (2/18) |
1 entry |
ENSG00000137497 |
|
adrenal cortex carcinoma |
missense_variant |
1.22% (2/164) |
1 entry |
ENSG00000137497 |
|
oral squamous cell carcinoma |
sequence_alteration |
0.9756% (2/205) |
2 entries |
ENSG00000137497 |
|
skin melanoma |
missense_variant |
2.068% (20/967) |
3 entries |
ENSG00000137497 |
|
acute myeloid leukemia |
sequence_alteration |
0.6615% (6/907) |
1 entry |
ENSG00000137497 |
|
lung adenocarcinoma |
missense_variant |
1.804% (21/1164) |
4 entries |
ENSG00000137497 |
|
chronic lymphocytic leukemia |
sequence_alteration |
0.5631% (5/888) |
1 entry |
ENSG00000137497 |
|
acute lymphoblastic leukemia |
stop_gained |
0.6231% (2/321) |
1 entry |
ENSG00000137497 |
|
gastric adenocarcinoma |
missense_variant |
3.093% (21/679) |
1 entry |
ENSG00000137497 |
|
acute lymphoblastic leukemia |
sequence_alteration |
0.6231% (2/321) |
1 entry |
ENSG00000137497 |
|
rectal adenocarcinoma |
missense_variant |
1.81% (4/221) |
1 entry |
ENSG00000137497 |
|
nasopharyngeal squamous cell carcinoma |
missense_variant |
1.198% (2/167) |
1 entry |
ENSG00000137497 |
|
esophageal adenocarcinoma |
sequence_alteration |
5.023% (22/438) |
1 entry |
ENSG00000137497 |
|
colorectal adenocarcinoma |
stop_gained |
7.55% (86/1139) |
1 entry |
ENSG00000137497 |
|
ovarian serous adenocarcinoma |
missense_variant |
0.5944% (4/673) |
1 entry |
ENSG00000137497 |
|
lung adenocarcinoma |
sequence_alteration |
1.804% (21/1164) |
4 entries |
ENSG00000137497 |
|
pancreatic ductal adenocarcinoma |
sequence_alteration |
3.098% (39/1259) |
1 entry |
ENSG00000137497 |
|
colon adenocarcinoma |
sequence_alteration |
3.453% (26/753) |
5 entries |
ENSG00000137497 |
|
breast carcinoma |
frameshift_variant |
1.063% (15/1411) |
1 entry |
ENSG00000137497 |
|
melanoma |
missense_variant |
3.96% (4/101) |
2 entries |
ENSG00000137497 |
|
squamous cell lung carcinoma |
missense_variant |
1.181% (9/762) |
1 entry |
ENSG00000137497 |
|
esophageal squamous cell carcinoma |
missense_variant |
1.778% (12/675) |
2 entries |
ENSG00000137497 |
|
papillary renal cell carcinoma |
missense_variant |
0.8955% (3/335) |
1 entry |
ENSG00000137497 |
|
Gallbladder Adenocarcinoma |
sequence_alteration |
2.299% (2/87) |
2 entries |
ENSG00000137497 |
|
colon adenocarcinoma |
frameshift_variant |
3.453% (26/753) |
2 entries |
ENSG00000137497 |
|
colon adenocarcinoma |
stop_gained |
3.453% (26/753) |
1 entry |
ENSG00000137497 |
|
colorectal adenocarcinoma |
sequence_alteration |
7.55% (86/1139) |
3 entries |
ENSG00000137497 |
|
colorectal adenocarcinoma |
missense_variant |
7.55% (86/1139) |
4 entries |
ENSG00000137497 |
|
breast ductal adenocarcinoma |
sequence_alteration |
8.562% (50/584) |
1 entry |
ENSG00000137497 |
|
cecum adenocarcinoma |
sequence_alteration |
3.053% (4/131) |
1 entry |
ENSG00000137497 |
|
hepatocellular carcinoma |
sequence_alteration |
1.221% (11/901) |
1 entry |
ENSG00000137497 |
|
prostate adenocarcinoma |
sequence_alteration |
2.545% (37/1454) |
2 entries |
ENSG00000137497 |
|
gastric adenocarcinoma |
sequence_alteration |
3.093% (21/679) |
1 entry |
ENSG00000137497 |
|
ovarian serous adenocarcinoma |
sequence_alteration |
0.5944% (4/673) |
1 entry |
ENSG00000137497 |
|
diffuse large B-cell lymphoma |
sequence_alteration |
0.9868% (3/304) |
1 entry |
ENSG00000137497 |
|
breast carcinoma |
missense_variant |
1.063% (15/1411) |
1 entry |
ENSG00000137497 |
|
female breast carcinoma |
missense_variant |
1.873% (5/267) |
1 entry |
ENSG00000137497 |
|
melanoma |
sequence_alteration |
3.96% (4/101) |
3 entries |
ENSG00000137497 |
|
colorectal adenocarcinoma |
frameshift_variant |
7.55% (86/1139) |
2 entries |
ENSG00000137497 |
|
acute myeloid leukemia |
frameshift_variant |
0.6615% (6/907) |
1 entry |
ENSG00000137497 |
|
basal cell carcinoma |
missense_variant |
6.897% (4/58) |
1 entry |
ENSG00000137497 |
|
squamous cell lung carcinoma |
sequence_alteration |
1.181% (9/762) |
1 entry |
ENSG00000137497 |
|
brain glioblastoma |
sequence_alteration |
0.7559% (7/926) |
1 entry |
ENSG00000137497 |
|
head and neck squamous cell carcinoma |
missense_variant |
0.9383% (7/746) |
2 entries |
ENSG00000137497 |
|
small cell lung carcinoma |
sequence_alteration |
1.881% (6/319) |
3 entries |
ENSG00000137497 |
|
prostate carcinoma |
missense_variant |
3.286% (14/426) |
2 entries |
ENSG00000137497 |
|
diffuse large B-cell lymphoma |
missense_variant |
0.9868% (3/304) |
2 entries |
ENSG00000137497 |
|
brain glioblastoma |
missense_variant |
0.7559% (7/926) |
1 entry |
ENSG00000137497 |
|
lung adenocarcinoma |
stop_gained |
1.804% (21/1164) |
1 entry |
ENSG00000137497 |
|
prostate adenocarcinoma |
missense_variant |
2.545% (37/1454) |
2 entries |
ENSG00000137497 |
|
esophageal adenocarcinoma |
missense_variant |
5.023% (22/438) |
1 entry |
ENSG00000137497 |
|
prostate carcinoma |
sequence_alteration |
3.286% (14/426) |
2 entries |
ENSG00000137497 |
|
gastric intestinal type adenocarcinoma |
missense_variant |
8.235% (7/85) |
2 entries |
ENSG00000137497 |
|
esophageal squamous cell carcinoma |
stop_gained |
1.778% (12/675) |
2 entries |
ENSG00000137497 |
|
breast ductal adenocarcinoma |
frameshift_variant |
8.562% (50/584) |
1 entry |
ENSG00000137497 |
|
basal cell carcinoma |
sequence_alteration |
6.897% (4/58) |
1 entry |
ENSG00000137497 |
|
oral squamous cell carcinoma |
frameshift_variant |
0.9756% (2/205) |
1 entry |
ENSG00000137497 |
|
head and neck squamous cell carcinoma |
frameshift_variant |
0.9383% (7/746) |
1 entry |
ENSG00000137497 |
|
female breast carcinoma |
frameshift_variant |
1.873% (5/267) |
1 entry |
ENSG00000137497 |
|
colon adenocarcinoma |
conservative_inframe_deletion |
3.453% (26/753) |
1 entry |
ENSG00000137497 |
|
osteosarcoma |
sequence_alteration |
0.8621% (1/116) |
1 entry |
ENSG00000137497 |
|
Cervical Small Cell Carcinoma |
sequence_alteration |
16.67% (1/6) |
1 entry |
ENSG00000137497 |
|
Merkel cell skin cancer |
missense_variant |
3.333% (1/30) |
1 entry |
ENSG00000137497 |
|
Mantle cell lymphoma |
missense_variant |
2.439% (1/41) |
1 entry |
ENSG00000137497 |
|
small cell lung carcinoma |
frameshift_variant |
1.881% (6/319) |
1 entry |
ENSG00000137497 |
|
Fibroadenoma |
missense_variant |
12.5% (1/8) |
1 entry |
ENSG00000137497 |
|
cecum adenocarcinoma |
stop_gained |
3.053% (4/131) |
1 entry |
ENSG00000137497 |
|
head and neck squamous cell carcinoma |
sequence_alteration |
0.9383% (7/746) |
1 entry |
ENSG00000137497 |
|
primary peritoneal carcinoma (disease) |
sequence_alteration |
100.0% (1/1) |
1 entry |
ENSG00000137497 |
|
Pleural Epithelioid Mesothelioma |
stop_lost |
1.064% (1/94) |
1 entry |
ENSG00000137497 |
|
Fibroadenoma |
sequence_alteration |
12.5% (1/8) |
1 entry |
ENSG00000137497 |
|
embryonal rhabdomyosarcoma |
sequence_alteration |
1.316% (1/76) |
1 entry |
ENSG00000137497 |
|
embryonal rhabdomyosarcoma |
missense_variant |
1.316% (1/76) |
1 entry |
ENSG00000137497 |
|
central nervous system primitive neuroectodermal neoplasm |
sequence_alteration |
0.2268% (1/441) |
1 entry |
ENSG00000137497 |
|
Cervical Small Cell Carcinoma |
missense_variant |
16.67% (1/6) |
1 entry |
ENSG00000137497 |
|
endometrial carcinoma |
sequence_alteration |
4.348% (1/23) |
1 entry |
ENSG00000137497 |
|
gastric intestinal type adenocarcinoma |
stop_gained |
8.235% (7/85) |
1 entry |
ENSG00000137497 |
|
non-small cell lung carcinoma |
missense_variant |
1.887% (1/53) |
1 entry |
ENSG00000137497 |
|
primary peritoneal carcinoma (disease) |
missense_variant |
100.0% (1/1) |
1 entry |
ENSG00000137497 |
|
head and neck squamous cell carcinoma |
stop_gained |
0.9383% (7/746) |
1 entry |
ENSG00000137497 |
|
pharyngeal squamous cell carcinoma |
missense_variant |
3.226% (1/31) |
1 entry |
ENSG00000137497 |
|
Ampulla of Vater Carcinoma |
missense_variant |
1.176% (1/85) |
1 entry |
ENSG00000137497 |
|
pancreatic ductal adenocarcinoma |
amino_acid_insertion |
3.098% (39/1259) |
1 entry |
ENSG00000137497 |
|
pancreatic ductal adenocarcinoma |
missense_variant |
3.098% (39/1259) |
1 entry |
ENSG00000137497 |
|
Mantle cell lymphoma |
sequence_alteration |
2.439% (1/41) |
1 entry |
ENSG00000137497 |
|
large cell lung carcinoma |
sequence_alteration |
11.11% (2/18) |
1 entry |
ENSG00000137497 |
|
hemangioblastoma |
sequence_alteration |
10.0% (1/10) |
1 entry |
ENSG00000137497 |
|
endometrial carcinoma |
missense_variant |
4.348% (1/23) |
1 entry |
ENSG00000137497 |
|
ovarian serous adenocarcinoma |
conservative_inframe_deletion |
0.5944% (4/673) |
1 entry |
ENSG00000137497 |
|
hepatocellular carcinoma |
stop_gained |
1.221% (11/901) |
1 entry |
ENSG00000137497 |
|
mucosal melanoma |
sequence_alteration |
7.143% (1/14) |
1 entry |
ENSG00000137497 |
|
non-small cell lung carcinoma |
sequence_alteration |
1.887% (1/53) |
1 entry |
ENSG00000137497 |
|
gastric adenocarcinoma |
frameshift_variant |
3.093% (21/679) |
1 entry |
ENSG00000137497 |
|
Gallbladder Adenocarcinoma |
missense_variant |
2.299% (2/87) |
1 entry |
ENSG00000137497 |
|
hemangioblastoma |
missense_variant |
10.0% (1/10) |
1 entry |
ENSG00000137497 |
|
gastric intestinal type adenocarcinoma |
frameshift_variant |
8.235% (7/85) |
1 entry |
ENSG00000137497 |
|
melanoma |
frameshift_variant |
3.96% (4/101) |
1 entry |
ENSG00000137497 |
|
colorectal adenocarcinoma |
conservative_inframe_deletion |
7.55% (86/1139) |
1 entry |